How Much Weight Do You Lose Weekly on Semaglutide?

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, leading to reduced appetite and lower calorie intake. Clinical trials show that patients lose weight gradually and consistently, with the most dramatic changes occurring in the first three months of treatment. PlexusDx delivers compounded semaglutide injections tailored to your individual response, starting at just $189 per month.

Average Weekly Weight Loss Timeline on Semaglutide

During the first four weeks of semaglutide therapy, most patients experience minimal weight loss as their body adjusts to the medication. This initial phase typically shows a loss of 0.5–1 pound per week. By weeks 5–12, as doses increase and your body fully adapts to the GLP-1 receptor signal, weekly losses accelerate to 1–2 pounds. This acceleration reflects both reduced appetite and improved metabolic efficiency, which continues as long as the medication is taken consistently.

After the first three months, the rate of weight loss often stabilizes at 0.5–1.5 pounds weekly through month six. Total weight loss by six months averages 10–15% of starting body weight in clinical trials, though this number varies significantly. By one year, many patients reach 15–22% weight reduction. The speed of loss depends on your initial weight, adherence to healthy eating habits, physical activity level, and how your individual GLP-1 and GIP receptors respond to the medication.

Factors That Influence Your Personal Weekly Weight Loss Rate

Starting weight is one of the strongest predictors of total weight loss on semaglutide. Patients weighing more than 250 pounds often lose weight faster in absolute pounds during the first 12 weeks than those starting at lower weights. Your metabolic baseline also matters: individuals with insulin resistance or type 2 diabetes may see different early results than those without glucose metabolism issues. Age, sex, and prior weight loss attempts all shape how quickly your body responds to appetite suppression.

Lifestyle choices during semaglutide treatment directly impact weekly weight loss numbers. Patients who maintain a structured eating plan and exercise 150+ minutes weekly lose weight 1.5× faster than those who rely on medication alone. Hydration, sleep quality, and stress management also influence metabolism and appetite hormone balance. PlexusDx recommends consulting a registered dietitian to optimize your nutrition plan alongside semaglutide therapy, ensuring you lose fat while preserving lean muscle mass.

Genetic Factors and Personalized Weight Loss Prediction

Your genetic makeup influences how effectively semaglutide suppresses appetite and promotes weight loss. The GLP1R rs6923761 variant affects how sensitively your GLP-1 receptors respond to the medication, potentially altering your weekly loss rate. The FTO rs9939609 variant correlates with baseline appetite regulation and fat storage patterns. The GIPR rs1800437 and MC4R rs17782313 variants further modify your individual metabolic response to GLP-1 and GIP signaling.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How to Maximize Your Weekly Weight Loss on Semaglutide

Consistency with your injection schedule is essential for steady weekly weight loss. PlexusDx compounded semaglutide injections maintain stable medication levels when taken every seven days, preventing appetite rebound and metabolic slowdown. Missing doses or irregular timing can reduce your weekly loss rate by 30–50% and increase the risk of regaining weight. Setting a reminder on your phone or calendar ensures you never miss your injection day.

Combine semaglutide with a protein-rich, low-processed-food diet to preserve muscle and maximize fat loss during your weekly weigh-ins. Aim for 25–35 grams of protein per meal, adequate fiber intake, and consistent meal timing to work with your medication's appetite-suppressing effects. Strength training two to three times weekly maintains lean tissue as you lose weight, preventing metabolic slowdown. These strategies, paired with PlexusDx semaglutide therapy at $189/mo month-to-month, or from $149/mo on the 6-month plan, create the conditions for sustainable 1–2 pound weekly losses.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is 1–2 pounds per week safe on semaglutide?

Yes, 1–2 pounds weekly falls within the safe range recommended by the American Academy of Obesity Medicine. This rate allows your body to lose primarily fat tissue while preserving muscle and bone density. PlexusDx monitors your progress and adjusts your semaglutide dose to maintain safe, sustainable weight loss throughout your treatment.

Why is my weekly weight loss slower than my friend's on semaglutide?

Individual weight loss rates vary due to genetics, baseline metabolism, diet adherence, exercise, age, and starting weight. Your friend may have different GLP-1 receptor sensitivity, influenced by their GLP1R rs6923761 genetic variant, which explains faster losses. PlexusDx's Precision Peptide Genetic Test identifies your specific metabolic profile to set realistic expectations and optimize your therapy.

Can I reach my weight loss goal faster by increasing my semaglutide dose?

Higher doses do not guarantee faster weekly weight loss and increase the risk of side effects like nausea or gastrointestinal discomfort. PlexusDx follows a gradual dose escalation protocol that maximizes weight loss while minimizing adverse effects. Your dose may increase over time as your body adapts, but pricing remains flat at $149 per month for semaglutide injections—your dose won't change your price.

What if I stop losing weight weekly after three months?

A weight loss plateau after 12 weeks is common and reflects your body's adaptation to the medication and new weight level. Adjusting your diet composition, increasing exercise intensity, or switching to PlexusDx's dual-compound GLP-Squared injection (combining semaglutide and tirzepatide) can restart weekly loss. PlexusDx providers personalize your plan to overcome plateaus and continue progressing toward your goal.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Semaglutide For Weight Loss 2

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.